Clinical Trials · NCT04569591
DDAVP for Pituitary Adenoma
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Enrollment
- 22
- Start date
- Mar 2026
- Locations
- 1 site, United States
- Primary endpoint
- The primary outcome measure will be defined as whether or not DDAVP-stimulated PET imaging demonstrates tumor in MRI-negative cases.